Eli Lilly CEO says Britain’s strict regime means it could miss out on new drugs being rolled out unless it pays more
The chief executive of the pharmaceutical company Eli Lilly has said the UK is “probably the worst country in Europe” for drug prices, amid a row between the industry and government.
Dave Ricks said that the UK’s strict pricing regime, allowing it to pay less for drugs than other developed countries, means it would miss out on new drugs being rolled out if it did not raise prices and scrap a rebate scheme.
Continue reading...